Publications by authors named "Julie Crider"

Claim this Profile
M
Microcannula Injection of Large Gel Particle Hyaluronic Acid for Cheek Augmentation and the Correction of Age-Related Midface Contour Deficiencies.
Derek H Jones, Jill Hessler, Anne Chapas, Brandie Jonas, Julie Crider

Dermatol Surg· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ophthalmic preservatives: focus on polyquaternium-1.
Maurizio Rolando, Julie Y Crider, Malik Y Kahook

Expert Opin Drug Deliv· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human choroidal melanocyte signal transduction responses to various pharmacological agents: focus on endothelin receptors.
Najam A Sharif, Julie Y Crider

Curr Eye Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracellular signaling in human iridial fibroblasts and iridial melanocytes in response to prostaglandins, endothelin, isoproterenol, and other pharmacological agents.
Najam A Sharif, Julie Y Crider

Curr Eye Res· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serotonin-2 (5-HT2) receptor-mediated signal transduction in human ciliary muscle cells: role in ocular hypotension.
Najam A Sharif, Curtis R Kelly, Julie Y Crider, Terry L Davis

J Ocul Pharmacol Ther· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical pharmacology of AL-12182, a new ocular hypotensive 11-oxa prostaglandin analog.
Najam A Sharif, Marsha A McLaughlin, Curtis R Kelly, Shouxi Xu, Julie Y Crider

J Ocul Pharmacol Ther· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ophthalmic infections and their anti-infective challenges.
Eduardo Alfonso, Julie Crider

Surv Ophthalmol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes.
Naj A Sharif, Gary W Williams, Julie Y Crider, Shouxi X Xu, Terry L Davis

J Ocul Pharmacol Ther· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cloned human 5-HT1A receptor pharmacology determined using agonist binding and measurement of cAMP accumulation.
Najam A Sharif, Colene D Drace, Gary W Williams, Julie Y Crider

J Pharm Pharmacol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.
Robert Abshire, Paul Cockrum, Julie Crider, Barry Schlech

Clin Ther· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells.
Julie Y Crider, Gary W Williams, Colene D Drace, Parvaneh Katoli, Michelle Senchyna

Invest Ophthalmol Vis Sci· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human ciliary muscle cell responses to FP-class prostaglandin analogs: phosphoinositide hydrolysis, intracellular Ca2+ mobilization and MAP kinase activation.
Naj A Sharif, Julie Y Crider, Shahid Husain, Ismail Kaddour-Djebbar, Habib R Ansari

J Ocul Pharmacol Ther· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.
Najam A Sharif, Curtis R Kelly, Julie Y Crider

Invest Ophthalmol Vis Sci· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-Oxa-15-cyclohexyl prostaglandin DP receptor agonists as topical antiglaucoma agents.
Mark R Hellberg, Raymond E Conrow, Najam A Sharif, Marsha A McLaughlin, John E Bishop, Julie Y Crider

Bioorg Med Chem· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenylyl cyclase activity mediated by beta-adrenoceptors in immortalized human trabecular meshwork and non-pigmented ciliary epithelial cells.
Julie Y Crider, Najam A Sharif

J Ocul Pharmacol Ther· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis